Filing Details
- Accession Number:
- 0001225208-18-007833
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-17 17:56:44
- Reporting Period:
- 2018-04-16
- Accepted Time:
- 2018-04-17 17:56:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1168014 | M Mirian Weir Graddick | Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033 | Exe V-P, Hr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-16 | 24,000 | $58.00 | 80,433 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
- Holdings include shares acquired in dividend reinvestment transactions.
Billionaire Hedge Funds
